Therefore, in the early stage of tumor progression, ROS can change the antitumorigenic function of TGF-β to a pro-tumorigenic function, as well as this ROS–TGF-β relationship being able to produce the cancer phenotype. Here, TGFB1 is linked to neoplasm.